Hydroxychloroquine and postoperative thromboembolism after total hip replacement
Identifieur interne : 003252 ( Main/Exploration ); précédent : 003251; suivant : 003253Hydroxychloroquine and postoperative thromboembolism after total hip replacement
Auteurs : James R. Loudon [Royaume-Uni]Source :
- The American Journal of Medicine [ 0002-9343 ] ; 1988.
English descriptors
- Teeft :
- American journal, Arthroplasty, Charnley, Clin orthop, Deep infection, Deep vein thrombosis, Dose heparin, Embolism, Fibrinogen, Fibrinogen uptake test, Heparin, Hydroxychloroquine, John charnley, Lancet, Loudon, Medicine volume, Patient intolerance, Patient tolerance, Prophylaxis, Pulmonary embolism, Surg, Surgical patients, Thromboembolism, Thrombosis, Venous, Wound healing, Wrightington, Wrightington hospital.
Abstract
Abstract: Evidence for the usefulness of hydroxychloroquine as prophylaxis against thromboembolism after total hip replacement is examined. This agent causes reduction in red blood cell aggregation without prolonging the bleeding time in humans and, experimentally, reduces the size of the thrombus. There is a variably demonstrable reduction in platelet aggregation and blood viscosity in humans. After hip replacement, the venographic incidence of deep vein thrombosis is not influenced by hydroxychloroquine. The incidence of fatal pulmonary embolism appears to be reduced, but a controlled trial against placebo does not exist. There are no serious or irreversible side effects, and wound healing is not affected by the administration of this drug. Hydroxychloroquine remains the prophylaxis of choice in use at the Hip Center, Wrightington Hospital, England, 13 years after its introduction.
Url:
DOI: 10.1016/0002-9343(88)90364-6
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000071
- to stream Istex, to step Curation: 000071
- to stream Istex, to step Checkpoint: 002014
- to stream Main, to step Merge: 003323
- to stream Main, to step Curation: 003252
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hydroxychloroquine and postoperative thromboembolism after total hip replacement</title><author><name sortKey="Loudon, James R" sort="Loudon, James R" uniqKey="Loudon J" first="James R." last="Loudon">James R. Loudon</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:55EED8586CCA2E3C97198B4B3BB6C137CD6C659F</idno><date when="1988" year="1988">1988</date><idno type="doi">10.1016/0002-9343(88)90364-6</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-KNNSR5WJ-2/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000071</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000071</idno><idno type="wicri:Area/Istex/Curation">000071</idno><idno type="wicri:Area/Istex/Checkpoint">002014</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002014</idno><idno type="wicri:doubleKey">0002-9343:1988:Loudon J:hydroxychloroquine:and:postoperative</idno><idno type="wicri:Area/Main/Merge">003323</idno><idno type="wicri:Area/Main/Curation">003252</idno><idno type="wicri:Area/Main/Exploration">003252</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Hydroxychloroquine and postoperative thromboembolism after total hip replacement</title><author><name sortKey="Loudon, James R" sort="Loudon, James R" uniqKey="Loudon J" first="James R." last="Loudon">James R. Loudon</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Orthopedic Surgery, Victoria Infirmary, Langside, Glasgow</wicri:regionArea><wicri:noRegion>Glasgow</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">The American Journal of Medicine</title><title level="j" type="abbrev">AJM</title><idno type="ISSN">0002-9343</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1988">1988</date><biblScope unit="volume">85</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="supplement">S1</biblScope><biblScope unit="page" from="57">57</biblScope><biblScope unit="page" to="61">61</biblScope></imprint><idno type="ISSN">0002-9343</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0002-9343</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>American journal</term><term>Arthroplasty</term><term>Charnley</term><term>Clin orthop</term><term>Deep infection</term><term>Deep vein thrombosis</term><term>Dose heparin</term><term>Embolism</term><term>Fibrinogen</term><term>Fibrinogen uptake test</term><term>Heparin</term><term>Hydroxychloroquine</term><term>John charnley</term><term>Lancet</term><term>Loudon</term><term>Medicine volume</term><term>Patient intolerance</term><term>Patient tolerance</term><term>Prophylaxis</term><term>Pulmonary embolism</term><term>Surg</term><term>Surgical patients</term><term>Thromboembolism</term><term>Thrombosis</term><term>Venous</term><term>Wound healing</term><term>Wrightington</term><term>Wrightington hospital</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Evidence for the usefulness of hydroxychloroquine as prophylaxis against thromboembolism after total hip replacement is examined. This agent causes reduction in red blood cell aggregation without prolonging the bleeding time in humans and, experimentally, reduces the size of the thrombus. There is a variably demonstrable reduction in platelet aggregation and blood viscosity in humans. After hip replacement, the venographic incidence of deep vein thrombosis is not influenced by hydroxychloroquine. The incidence of fatal pulmonary embolism appears to be reduced, but a controlled trial against placebo does not exist. There are no serious or irreversible side effects, and wound healing is not affected by the administration of this drug. Hydroxychloroquine remains the prophylaxis of choice in use at the Hip Center, Wrightington Hospital, England, 13 years after its introduction.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Loudon, James R" sort="Loudon, James R" uniqKey="Loudon J" first="James R." last="Loudon">James R. Loudon</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003252 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003252 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:55EED8586CCA2E3C97198B4B3BB6C137CD6C659F
|texte= Hydroxychloroquine and postoperative thromboembolism after total hip replacement
}}
| This area was generated with Dilib version V0.6.33. |  |